Healthcare Services

Global Low-Density Lipoprotein Test Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses

April 2, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Low-Density Lipoprotein Test Market Across 2026–2030?

The low-density lipoprotein test market has shown substantial growth in recent years. It is anticipated to increase from $8.83 billion in 2025 to $9.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.5%. This historical expansion can be linked to factors such as the rising incidence of cardiovascular diseases, the early clinical use of ldl-c testing, an increase in obesity and diabetes, the expansion of hospital-based diagnostic laboratories, and improved awareness of cholesterol management.

The low-density lipoprotein test market size is anticipated to undergo significant expansion in the coming years, with projections indicating it will reach $11.47 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.3%. The drivers behind this growth during the forecast period encompass an increasing emphasis on preventive healthcare, a rise in screening for dyslipidaemia, the expanding application of advanced lipid testing methods, a growing demand for early detection of stroke and heart disease risks, and higher healthcare spending allocated to diagnostics. Prominent trends throughout the forecast period include a heightened focus on preventive cardiovascular screening, the growing utilization of comprehensive lipid panel testing, an increasing demand for routine cholesterol monitoring, the expansion of ldl testing in the context of metabolic disorders, and the rising adoption of point-of-care lipid testing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9395&type=smp

Which Market Drivers Are Supporting The Expansion Of The Low-Density Lipoprotein Test Market?

The increasing prevalence of cardiovascular diseases is anticipated to propel the growth of the low-density lipoprotein test market going forward. Cardiovascular diseases are defined as conditions that impact the heart or blood vessels. The LDL test is utilized to assist in the management of cardiovascular diseases by directly assessing low-density lipoprotein levels. For instance, in February 2024, according to the UK Parliament, a UK-based governing body, heart and circulatory diseases are responsible for approximately 25% of all deaths in England, leading to over 140,000 fatalities annually and around 480 each day, or one death every three minutes. Consequently, the rise in the prevalence of cardiovascular diseases is driving the expansion of the low-density lipoprotein test market.

What Segmentation Levels Are Considered In The Low-Density Lipoprotein Test Market?

The low-density lipoprotein test market covered in this report is segmented –

1) By Product Type: Low-Density Lipoprotein Cholesterol (LDL-C), Low-Density Lipoprotein Particle Number (LDL-P), Low-Density Lipoprotein Particle Size (LDL-B), Other Product Types

2) By Component: Kits, Reagents, Devices, Other Components

3) By Disease Type: Diabetes, Stroke, Atherosclerosis, Obesity, Dyslipidaemia, Carotid Artery Disease, Peripheral Arterial Disease, Angina, Other Disease Types

4) By Distribution Channel: Direct Tenders, Retail

5) By End User: Hospitals, Clinics, Ambulatory Care, Research Laboratory, Other End Users

Subsegments:

1) By Low-Density Lipoprotein Cholesterol (LDL-C): Direct Measurement Tests, Calculated LDL-C Tests

2) By Low-Density Lipoprotein Particle Number (LDL-P): NMR (Nuclear Magnetic Resonance) Tests, Other Particle Counting Methods

3) By Low-Density Lipoprotein Particle Size (LDL-B): Gradient Gel Electrophoresis, Other Size Measurement Techniques

4) By Other Product Types: Lipid Panel Tests: Genetic Testing For Dyslipidemia, Point-Of-Care Testing Devices

What Industry Trends Are Redefining The Low-Density Lipoprotein Test Market?

Leading companies in the low-density lipoprotein (LDL) test market are concentrating on introducing innovative diagnostic solutions, such as advanced lipoprotein analysis systems, to improve cardiovascular risk assessment, diagnostic accuracy, and patient management. These advanced lipoprotein analysis systems utilize technologies like nuclear magnetic resonance (NMR) spectroscopy and algorithm-driven interpretation to offer deeper insights into lipid profiles beyond standard LDL-C measurements, thereby enhancing clinical decision-making for individuals with cardiometabolic risks. As an illustration, in July 2023, Numares Health, a Germany-based health diagnostic company, introduced the AXINON LDL-p Test System. This FDA-cleared diagnostic tool provides a more detailed assessment of lipoproteins, offering insights into cardiac function that go beyond standard LDL-C measurements. Employing nuclear magnetic resonance (NMR) spectroscopy, the system incorporates advanced diagnostic algorithms to boost its accuracy. It aids physicians in better managing patients at elevated risk for cardiovascular disease, particularly those with cardiometabolic risk factors.

Which Leading Firms Are Contributing To The Growth Of The Low-Density Lipoprotein Test Market?

Major companies operating in the low-density lipoprotein test market are Abbott Laboratories, Siemens Healthineers, F Hoffmann La Roche Ltd, Danaher Corporation, Thermo Fisher Scientific Inc, Bio Rad Laboratories Inc, DiaSorin SpA, Randox Laboratories Ltd, Sekisui Diagnostics, DiaSys Diagnostic Systems GmbH, Eurolyser Diagnostica GmbH, Diazyme Laboratories Inc, OPKO Health Inc, Merck KGaA, Agilent Technologies Inc, Becton Dickinson and Company, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Eurofins Scientific SE, Home Access Health Corporation

Read the full low-density lipoprotein test market report here:

https://www.thebusinessresearchcompany.com/report/low-density-lipoprotein-test-global-market-report

How Is The Low-Density Lipoprotein Test Market Distributed Across Key Geographic Regions?

North America was the largest region in the Low-Density Lipoprotein Test market in 2025. The regions covered in the low-density lipoprotein test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Low-Density Lipoprotein Test Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9395&type=smp

Browse Through More Reports Similar to the Global Low-Density Lipoprotein Test Market 2026, By The Business Research Company

Cholesterol Test Global Market Report

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Lipid Panel Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Poc Cholesterol Test Market

https://www.thebusinessresearchcompany.com/report/poc-cholesterol-test-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795